316885772	316885772	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
66656635	66656635	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8374887	8374887	CD	B-NP	O
|	|	CC	I-NP	O
8/19/2004	8/19/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
REACTIVE	REACTIVE	NNP	I-NP	I-protein
AIRWAY	AIRWAY	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/7/2004	7/7/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/8/2004	9/8/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BRICE	BRICE	NNP	B-NP	O
ARMSON	ARMSON	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
second	second	JJ	B-NP	O
hand	hand	NN	I-NP	O
smoke	smoke	NN	I-NP	O
inhalation	inhalation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
3	3	CD	I-NP	O
to	to	TO	B-PP	O
4-hour	4-hour	JJ	B-NP	O
period	period	NN	I-NP	O
while	while	IN	B-SBAR	O
lying	lie	VBG	B-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
wheezing	wheeze	VBG	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
eating	eating	NN	I-NP	O
habits	habit	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
missed	miss	VBD	B-VP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
PND	PND	NN	I-NP	O
,	,	,	I-NP	O
DOE	DOE	NN	I-NP	O
or	or	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
noticed	notice	VBN	I-VP	O
increased	increase	VBN	B-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Atrovent	Atrovent	NNP	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unknown	unknown	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
at	at	IN	B-PP	O
97.5	97.5	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
71	71	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
111/63	111/63	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
significant	significant	JJ	I-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
DVD	DVD	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
gallops	gallop	NNS	B-NP	O
being	be	VBG	B-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
rales	rale	NNS	I-NP	O
however	however	RB	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
Chem	Chem	NNP	I-NP	O
7	7	CD	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hyponitremia	hyponitremia	NN	B-NP	O
at	at	IN	B-PP	O
132	132	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
at	at	IN	B-PP	O
5.4	5.4	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
BNP	BNP	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
189	189	CD	B-NP	O
.	.	.	O	O

First	First	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	I-protein
cardiac	cardiac	JJ	B-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
MI	MI	NN	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Coreg	Coreg	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Included	Included	NNP	B-NP	O
Captopril	Captopril	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
gave	give	VBD	B-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lived	live	VBD	B-VP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
.	.	.	O	O

Denied	Deny	VBN	B-VP	O
any	any	DT	B-NP	O
drinking	drinking	NN	I-NP	O
and	and	CC	I-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
however	however	RB	B-VP	O
did	do	VBD	I-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
second	second	JJ	I-NP	O
hand	hand	NN	I-NP	O
smoke	smoke	NN	I-NP	O
inhalation	inhalation	NN	I-NP	O
history	history	NN	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
having	have	VBG	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
during	during	IN	B-PP	O
their	their	PRP$	B-NP	O
many	many	JJ	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
marriage	marriage	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
instant	instant	JJ	I-NP	O
V	V	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
then	then	RB	B-ADVP	O
a	a	DT	B-NP	O
two-vessel	two-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
SVG	SVG	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
stenosis	stenosis	NN	B-NP	O
to	to	TO	B-PP	O
then	then	RB	B-ADVP	O
to	to	TO	B-PP	O
VStent	VStent	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1988	1988	CD	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
SVG	SVG	NN	I-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	JJ	I-NP	O
placed	placed	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
VF	VF	NN	I-NP	O
and	and	CC	O	O
presumably	presumably	RB	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
smoke	smoke	NN	B-NP	O
inhalation	inhalation	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
presumes	presume	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	B-protein
or	or	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
precipitated	precipitate	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cycled	cycle	VBN	I-VP	O
through	through	IN	B-PP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
any	any	DT	B-NP	O
moment	moment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
any	any	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
statin	statin	NN	I-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
oscillated	oscillate	VBN	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
mildly	mildly	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
to	to	TO	B-PP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
that	that	DT	B-NP	O
way	way	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
wall	wall	NN	I-NP	O
thickness	thickness	NN	I-NP	O
with	with	IN	B-PP	O
overall	overall	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
being	be	VBG	B-VP	O
moderately	moderately	RB	B-ADVP	O
in	in	IN	B-PP	O
pair	pair	NN	B-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
severe	severe	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	I-NP	O
akinesis	akinesis	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
distal	distal	JJ	I-NP	O
septum	septum	NN	I-NP	O
apex	apex	NN	I-NP	O
and	and	CC	O	O
distal	distal	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
abnormal	abnormal	JJ	B-NP	O
septal	septal	JJ	I-NP	O
motion	motion	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
intraventricular	intraventricular	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
delay	delay	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ICP	ICP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
calcified	calcify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
enlarged	enlarge	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
velocity	velocity	NN	B-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
m/second	m/second	NN	I-NP	O
detecting	detect	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
33mmHg	33mmHg	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
since	since	IN	B-PP	O
7/26	7/26	CD	B-NP	O
there	there	EX	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
interval	interval	NN	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADVP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
significant	significant	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
like	like	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
her	her	PRP	B-NP	O
being	be	VBG	B-VP	O
relatively	relatively	RB	B-NP	O
refractory	refractory	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
way	way	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
Duonebs	Duoneb	NNS	B-NP	O
and	and	CC	O	O
albuterol	albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
2-2	2-2	CD	B-NP	O
hours	hour	NNS	I-NP	O
alternating	alternate	VBG	B-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
change	change	VB	I-VP	O
her	her	PRP	B-NP	O
from	from	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
prednisone	prednisone	NN	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Tessalon	Tessalon	NNP	B-NP	O
Perles	Perles	NNP	I-NP	O
and	and	CC	O	O
guaifenesin	guaifenesin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
so	so	RB	B-SBAR	O
as	as	IN	I-SBAR	O
to	to	TO	B-VP	O
possibly	possibly	RB	I-VP	O
treat	treat	VB	I-VP	O
any	any	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
only	only	RB	B-NP	O
some	some	DT	I-NP	O
interstitial	interstitial	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
focal	focal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
p.o.	p.o.	FW	B-NP	O
prednisone	prednisone	NN	I-NP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
uncontrolled	uncontrolled	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
a	a	DT	B-NP	O
finger	finger	NN	I-NP	O
stick	stick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
fully	fully	RB	I-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
non-gap	non-gap	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
.	.	.	O	O

Anticipating	Anticipate	VBG	B-VP	O
possible	possible	JJ	B-NP	O
decay	decay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
regular	regular	JJ	B-NP	O
lab	lab	NN	I-NP	O
draws	draw	NNS	I-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
drips	drip	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
gap	gap	NN	I-NP	B-protein
promptly	promptly	RB	B-ADVP	O
closed	close	VBD	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
receiving	receive	VBG	I-VP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	I-NP	O
p.m.	p.m.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
VNA	VNA	NN	I-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
included	include	VBD	B-VP	O
1	1	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin10	insulin10	NN	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
p.m.	p.m.	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
.	.	.	O	O

Flovent	Flovent	NNP	B-NP	O
,	,	,	O	O
Tessalon	Tessalon	NNP	B-NP	O
Perles	Perles	NNP	I-NP	O
and	and	CC	O	O
guaifenesin	guaifenesin	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Coreg	Coreg	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Cozaar	Cozaar	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Azithromycin	Azithromycin	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-6200678	9-6200678	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LUEKER	LUEKER	NNP	B-NP	O
,	,	,	O	O
DOMINIQUE	DOMINIQUE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JOSEPHPAULINE	JOSEPHPAULINE	NNP	B-NP	O
,	,	,	O	O
VINCENZO	VINCENZO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4960657	4960657	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/11/04	11/11/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/27/04	1/27/04	CD	B-NP	O

